JP2022546608A5 - - Google Patents
Info
- Publication number
- JP2022546608A5 JP2022546608A5 JP2022514994A JP2022514994A JP2022546608A5 JP 2022546608 A5 JP2022546608 A5 JP 2022546608A5 JP 2022514994 A JP2022514994 A JP 2022514994A JP 2022514994 A JP2022514994 A JP 2022514994A JP 2022546608 A5 JP2022546608 A5 JP 2022546608A5
- Authority
- JP
- Japan
- Prior art keywords
- adenosine deaminase
- fusion protein
- protein according
- base editor
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025122950A JP2025170240A (ja) | 2019-09-09 | 2025-07-23 | 新規核酸塩基エディター及びその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962897777P | 2019-09-09 | 2019-09-09 | |
| US62/897,777 | 2019-09-09 | ||
| USPCT/US2020/018195 | 2020-02-13 | ||
| PCT/US2020/018195 WO2020168135A1 (en) | 2019-02-13 | 2020-02-13 | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| PCT/US2020/049975 WO2021050571A1 (en) | 2019-09-09 | 2020-09-09 | Novel nucleobase editors and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122950A Division JP2025170240A (ja) | 2019-09-09 | 2025-07-23 | 新規核酸塩基エディター及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546608A JP2022546608A (ja) | 2022-11-04 |
| JP2022546608A5 true JP2022546608A5 (cg-RX-API-DMAC7.html) | 2023-09-19 |
| JP7717684B2 JP7717684B2 (ja) | 2025-08-04 |
Family
ID=74867196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514994A Active JP7717684B2 (ja) | 2019-09-09 | 2020-09-09 | 新規核酸塩基エディター及びその使用方法 |
| JP2025122950A Pending JP2025170240A (ja) | 2019-09-09 | 2025-07-23 | 新規核酸塩基エディター及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122950A Pending JP2025170240A (ja) | 2019-09-09 | 2025-07-23 | 新規核酸塩基エディター及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230075877A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4028026A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7717684B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220076467A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114667149A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020344547A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3153624A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021050571A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| WO2020168135A1 (en) * | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| CN114096666B (zh) | 2019-02-13 | 2025-03-18 | 比姆医疗股份有限公司 | 治疗血红素病变的组合物和方法 |
| AU2020344547A1 (en) * | 2019-09-09 | 2022-03-24 | Beam Therapeutics Inc. | Novel nucleobase editors and methods of using same |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| BR112023019539A2 (pt) * | 2021-03-26 | 2023-12-05 | Beam Therapeutics Inc | Variantes de adenosina desaminase e usos das mesmas |
| WO2022240858A1 (en) | 2021-05-10 | 2022-11-17 | Mammoth Biosciences, Inc. | Effector proteins and methods of use |
| KR20240012377A (ko) * | 2021-05-28 | 2024-01-29 | 빔 테라퓨틱스, 인크. | 염기 편집기의 자기-불활성화용 조성물 및 방법 |
| EP4363568A4 (en) * | 2021-06-29 | 2025-12-03 | Council Scient Ind Res | MODIFIED FNCAS9 AND ITS USES |
| EP4396207A4 (en) * | 2021-09-03 | 2025-07-16 | Univ Chicago | POLYPEPTIDES AND METHODS FOR MODIFYING NUCLEIC ACIDS |
| EP4399307A4 (en) * | 2021-09-08 | 2026-01-21 | Flagship Pioneering Innovations Vi Llc | HBB COMPOSITIONS AND MODULATION METHODS |
| EP4409000A1 (en) | 2021-09-28 | 2024-08-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Base editing approaches for the treatment of beta-hemoglobinopathies |
| WO2023099591A1 (en) | 2021-12-01 | 2023-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for increasing fetal hemoglobin content by editing the +55-kb region of the erythroid-specific bcl11a enhancer |
| WO2023141590A2 (en) | 2022-01-21 | 2023-07-27 | Mammoth Biosciences, Inc. | Effector proteins and methods of use |
| WO2023144104A1 (en) | 2022-01-25 | 2023-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Base editing approaches for the treatment of βeta-thalassemia |
| WO2023196802A1 (en) | 2022-04-04 | 2023-10-12 | The Broad Institute, Inc. | Cas9 variants having non-canonical pam specificities and uses thereof |
| CN120456933A (zh) | 2022-04-28 | 2025-08-08 | 布罗德研究所股份有限公司 | 编码碱基编辑器的aav载体及其用途 |
| WO2023217888A1 (en) | 2022-05-10 | 2023-11-16 | Institut National de la Santé et de la Recherche Médicale | Base editing approaches for correcting the cd39 (cag>tag) mutation in patients suffering from βeta-thalassemia |
| JP2025517657A (ja) | 2022-05-10 | 2025-06-10 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | シンシチン-1融合タンパク質及び標的細胞へのカーゴ送達のためのその使用 |
| EP4544035A4 (en) * | 2022-06-27 | 2026-06-24 | Beam Therapeutics Inc | ADENOSINE DEAMINASE BASIC EDITORS AND THEIR METHODS OF USE |
| WO2024018056A1 (en) | 2022-07-22 | 2024-01-25 | Institut National de la Santé et de la Recherche Médicale | Base editing approaches for correcting the ivs2-1 (g>a) mutation in patients suffering from βeta-thalassemia |
| CN115820691B (zh) * | 2022-07-25 | 2023-08-22 | 安徽农业大学 | 一种基于LbCpf1变体的水稻碱基编辑系统和应用 |
| AU2023325079A1 (en) | 2022-08-16 | 2025-02-13 | President And Fellows Of Harvard College | Evolved cytosine deaminases and methods of editing dna using same |
| CN115975986B (zh) * | 2022-08-22 | 2023-08-08 | 山东舜丰生物科技有限公司 | 突变的Cas12j蛋白及其应用 |
| WO2024063273A1 (en) * | 2022-09-23 | 2024-03-28 | Institute For Basic Science | Novel adenine deaminase variants and a method for base editing using the same |
| WO2024165484A1 (en) | 2023-02-06 | 2024-08-15 | Institut National de la Santé et de la Recherche Médicale | Enrichment of genetically modified hematopoietic stem cells through multiplex base editing |
| WO2024230760A1 (zh) * | 2023-05-09 | 2024-11-14 | 北京齐禾生科生物科技有限公司 | 一种可作用于dna的腺苷脱氨酶及其应用 |
| CN117965505A (zh) * | 2023-06-28 | 2024-05-03 | 微光基因(苏州)有限公司 | 工程化的腺苷脱氨酶及碱基编辑器 |
| KR20260044217A (ko) | 2023-07-25 | 2026-04-01 | 플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 | Cas 엔도뉴클레아제 및 관련 방법 |
| EP4777618A1 (en) * | 2023-09-15 | 2026-07-22 | Beam Therapeutics Inc. | Compositions and methods for base editing a phenylalanine hydroxylase polynucleotide |
| WO2025072331A1 (en) | 2023-09-26 | 2025-04-03 | Flagship Pioneering Innovations Vii, Llc | Cas nucleases and related methods |
| WO2025117877A2 (en) | 2023-12-01 | 2025-06-05 | Flagship Pioneering Innovations Vii, Llc | Cas nucleases and related methods |
| CN120536418A (zh) * | 2024-02-26 | 2025-08-26 | 尧唐(上海)生物科技有限公司 | 一种脱氨酶变体、包含其的碱基编辑器及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015332533B2 (en) * | 2014-10-14 | 2018-08-30 | Halozyme, Inc. | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same |
| WO2018027078A1 (en) * | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| US11242542B2 (en) * | 2016-10-07 | 2022-02-08 | Integrated Dna Technologies, Inc. | S. pyogenes Cas9 mutant genes and polypeptides encoded by same |
| KR20240007715A (ko) * | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| US11180778B2 (en) * | 2016-11-11 | 2021-11-23 | The Regents Of The University Of California | Variant RNA-guided polypeptides and methods of use |
| CA3082251A1 (en) * | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| AR114014A1 (es) * | 2017-12-22 | 2020-07-08 | Inst Genetics & Developmental Biology Cas | Sistema de edición de bases y método basado en proteína cpf1 |
| CN109295186B (zh) * | 2018-09-30 | 2023-10-03 | 中山大学 | 一种基于全基因组测序检测腺嘌呤单碱基编辑系统脱靶效应的方法及其在基因编辑中的应用 |
| AU2020344547A1 (en) * | 2019-09-09 | 2022-03-24 | Beam Therapeutics Inc. | Novel nucleobase editors and methods of using same |
-
2020
- 2020-09-09 AU AU2020344547A patent/AU2020344547A1/en active Pending
- 2020-09-09 EP EP20863422.0A patent/EP4028026A4/en active Pending
- 2020-09-09 CA CA3153624A patent/CA3153624A1/en active Pending
- 2020-09-09 JP JP2022514994A patent/JP7717684B2/ja active Active
- 2020-09-09 CN CN202080077983.2A patent/CN114667149A/zh active Pending
- 2020-09-09 WO PCT/US2020/049975 patent/WO2021050571A1/en not_active Ceased
- 2020-09-09 US US17/641,343 patent/US20230075877A1/en active Pending
- 2020-09-09 KR KR1020227011386A patent/KR20220076467A/ko active Pending
-
2025
- 2025-07-23 JP JP2025122950A patent/JP2025170240A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025170240A5 (cg-RX-API-DMAC7.html) | ||
| JP7197363B2 (ja) | ヌクレアーゼを使用するヒト神経幹細胞のゲノム編集 | |
| EP3178935B1 (en) | Genome editing using campylobacter jejuni crispr/cas system-derived rgen | |
| KR102796744B1 (ko) | 이식의 개선을 위한 crispr/cas-관련 방법 및 조성물 | |
| JP2025181841A5 (cg-RX-API-DMAC7.html) | ||
| JP2022545950A5 (cg-RX-API-DMAC7.html) | ||
| JP2021164463A (ja) | エピゲノム編集のための組成物および方法 | |
| US9914936B2 (en) | Nucleic acid silencing sequences | |
| WO2019042284A1 (en) | FUSION PROTEINS FOR ENHANCED PRECISION IN THE BASIC EDITION | |
| CA3151279A1 (en) | Highly efficient dna base editors mediated by rna-aptamer recruitment for targeted genome modification and uses thereof | |
| EP4022051A2 (en) | Compositions and methods for non-toxic conditioning | |
| JP2016165307A5 (cg-RX-API-DMAC7.html) | ||
| WO2017215648A1 (zh) | 基因敲除方法 | |
| CA2985615A1 (en) | Crispr/cas-related methods and compositions for treating hiv infection and aids | |
| CA3151816A1 (en) | Skeletal myoblast progenitor cell lineage specification by crispr/cas9-based transcriptional activators | |
| JP2023545497A5 (cg-RX-API-DMAC7.html) | ||
| CN104284669A (zh) | 治疗血红蛋白病的组合物和方法 | |
| JP2022532139A5 (cg-RX-API-DMAC7.html) | ||
| JP2024511163A5 (cg-RX-API-DMAC7.html) | ||
| WO2024006772A2 (en) | Adenosine deaminase base editors and methods for use thereof | |
| US20200140896A1 (en) | Methods for the treatment of disease with gene editing systems | |
| JP2021522825A5 (cg-RX-API-DMAC7.html) | ||
| EP3666898A1 (en) | Gene knockout method | |
| EP3868887A1 (en) | Novel virus vector and methods for producing and using same | |
| EP4665406A1 (en) | Crispr-transposon systems and components |